首页> 外文期刊>Life sciences >Enamel matrix derivative is a potent inhibitor of breast cancer cell attachment to bone.
【24h】

Enamel matrix derivative is a potent inhibitor of breast cancer cell attachment to bone.

机译:搪瓷基质衍生物是乳腺癌细胞附着在骨上的有效抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

This study examined whether enamel matrix derivative (EMD) inhibits the adhesion of cancer cells to bone. A typical breast cancer cell line, MCF-7, was used. Conditioned human osteosarcoma cell (Saos-2) medium was used as extracellular bone matrix (ECBM) to measure cell attachment. MCF-7 cells were incubated on ECBM-coated culture plates with or without soluble EMD, Arg-Gly-Asp (RGD) sequence blocking peptides, recombinant bone sialoprotein (rBSP), or specific integrin antibodies, and the attached cells were quantified using toluidine blue staining. EMD markedly reduced the attachment of MCF-7 cells to ECBM in a dose-dependent manner. An RGD peptide (GRGDSP) and recombinant BSP inhibited cell attachment to the same degree as EMD. Similarly, anti-alphavbeta3 integrin antibody strongly reduced cell attachment, whereas anti-alphavbeta5 and anti-beta1 integrin antibodies had less marked effects on cell attachment. These results show that EMD inhibits MCF-7 cell attachment to a bone matrix and that it mightbe useful as an anti-adhesive agent for breast cancer cells to bone in vivo.
机译:这项研究检查了釉质基质衍生物(EMD)是否抑制癌细胞对骨骼的粘附。使用了典型的乳腺癌细胞系MCF-7。条件人类骨肉瘤细胞(Saos-2)培养基用作细胞外骨基质(ECBM)来测量细胞附着。将MCF-7细胞在带有或不带有可溶性EMD,Arg-Gly-Asp(RGD)序列阻断肽,重组骨唾液蛋白(rBSP)或特定整合素抗体的ECBM包被的培养板上孵育,并使用甲苯胺对附着的细胞进行定量蓝色染色。 EMD以剂量依赖性方式显着降低了MCF-7细胞对ECBM的附着。 RGD肽(GRGDSP)和重组BSP抑制细胞附着的程度与EMD相同。同样,抗-αvbeta3整合素抗体强烈降低细胞粘附,而抗-αvbeta5和抗-β1整合素抗体对细胞粘附的影响较小。这些结果表明,EMD抑制MCF-7细胞附着在骨基质上,并可能用作乳腺癌细胞在体内与骨骼的抗粘连剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号